Moexipril detailed information

Moexipril detailed information

Clinical data
Pregnancy category	US: D (Evidence of risk)
Routes of administration	Oral
ATC code	C09AA13 (WHO)
Legal status
Legal status	UK: POM (Prescription only) US: ℞-only
Identifiers
IUPAC name (3S)-2-[(2S)-2-[ [(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid
CAS Number	103775-10-6
PubChem CID	91270
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C27H34N2O7
Molar mass	498.568 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Moexipril (marketed under the tradenames Univasc and Perdix) is an ACE inhibitor.

Template:ACE inhibitors Template:SIB